----
Current ValuationThe current P/E ratio is -171.04, below the reasonable range, cheaper than 99.23% of the time in the past 1 years, and the industry ranks 27/27, the industry Median 51.95.
-171.04xP/E
¥9.30Stock price
¥-0.05Earnings per share
-171.04xP/E
Stock price¥9.30Earnings per share¥-0.05
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -98.28x
- Typical range
- -155.19x–-58.94x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 51.95x
0113226339452
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 51.95x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688114SHMGI | -126.76x | 67.24% | ¥24.05B |
688202SHMedicilon | -102.79x | -- | ¥10.62B |
688068SHHotgen | -25.67x | -- | ¥6.66B |
603108SHRunda Medical | -11.76x | 137.36% | ¥6.06B |
300463SZmaccura | -171.04x | 369.81% | ¥5.62B |
301096SZBio-S | -26.15x | -- | ¥4.66B |
688238SHOBiO Tech | -19.14x | 18.92% | ¥4.19B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
